Put companies on watchlist
Acadia Healthcare
ISIN: US00404A1097
WKN: A1JNMF
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Acadia Healthcare · ISIN: US00404A1097 · PR Newswire (ID: 20241108DA52434)
09 November 2024 04:50AM

ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC


NEW ORLEANS, Nov. 8, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company's securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period"). This action is pending in the United States District Court for the Middle District of Tennessee.

What You May Do

If you purchased securities of Acadia and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-achc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 16, 2024.

About the Lawsuit

Acadia and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney's Office for the Southern District of New York as well as a grand jury subpoena from the United States District Court for the Western District of Missouri "related to its admissions, length of stay and billing practices." On this news, the price of Acadia's shares fell by $12.38 per share, or 16.36%, to close at $63.28 on September 27, 2024. Then, on October 18, 2024, The New York Times published a report entitled "Veterans Dept. Investigating Acadia Healthcare for Insurance Fraud" that highlighted claims regarding the Company's billing and patient holding and discharge practices. On this news, the price of Acadia's shares fell by $7.29 per share, or 12.28%, to close at $52.03 on October 18, 2024.

The case is Kachrodia v. Acadia Healthcare Company, Inc., No. 24-cv-01238.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com

1-877-515-1850

1100 Poydras St., Suite 960

New Orleans, LA 70163

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/acadia-healthcare-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick--foti-llc-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-acadia-healthcare-comp-302300451.html

SOURCE Kahn Swick & Foti, LLC

Visual performance / price development - Acadia Healthcare
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942